Future chat group

In the field of equity investment, Lei Hao is not without success stories. When VR was hot, they also made a fortune. During his time at Yingyi, Lei Hao even invested in movies, not to mention pharmaceutical companies. What was the result? Still successful.

The undefeated division refers to Thunder. This is a great aura, pressure, but also motivation.

Up to now, the entire Thunder Group has its own pride in its bones. Either don't do it, or if you do it, you must succeed, and you will definitely succeed!

Lei Hao promised 200 million yuan for the PNH treatment drug research project at the beginning, which is difficult to imagine for other companies. Even a charitable act needs to be discussed.

But it is logical to put it in the Thunder. Even Su Yiwen has secretly prepared the idea of ​​​​investing another 200 million if the 200 million is not enough. Using the cost to pile up the probability and maintaining the Thunder's successful tradition is what everyone values ​​​​more.

And everyone's view of Lei Hao is: No matter whether others can succeed or not, Mr. Lei can definitely do it.

Of course Ye Liu didn't understand this somewhat morbid idea, but as sensitive as he was, he noticed the sudden change in the atmosphere in the office. It seemed that... this group of people was different from usual.

"I have asked Mr. Su to pay attention to the expert database, and also asked Professor Li to submit more plans," Lei Hao smiled and said: "On this project, what we can do is, based on the opinions of the experts , decide which research project to let Professor Li carry out."

"Isn't this a layman's leadership?" Ye Liu was a little surprised.

"So we gave Professor Li a lot of autonomy. Besides, aren't the experts in the expert database also experts?" Lei Hao said.

"In the field of PNH therapeutic drug research in China, is there anyone more professional than Professor Li Yaotang?" Ye Liu said on Beepdog.

"It does exist internationally." Lei Hao shrugged.

Charity is so awesome. Not to mention China, even relevant foreign scholars would not object to taking time to provide guidance, not to mention that the Thunder also provided compensation.

Moreover, the research on rare disease treatment drugs is also an almost open field, because everyone knows that the probability of losing money is as high as 99.99%. This is almost a pure charity field. It is rare for donors to come in. Scholars still have to have moral integrity. They don’t want to be burdened with it. A bad reputation.

Therefore, Leiting has actually quietly gained some benefits, that is, it has established a better connection with the scholar circle. Li Miaotang's experiment is an example, allowing everyone to see the stupid side of Leiting, which is very popular among scholars. .

Of course, the relevant personnel definitely do not want to scare away Lei Lei. They very much hope that Lei Lei can help Li Miaotang make progress in the experiment.

In Lei Hao's drawer, there is a stack of invitations to academic research conferences. They are all sent by scholars with emotional intelligence. They have no idea what it means to invite a businessman to participate in an academic research field that is destined to lose money. What a ridiculous thing.

"I reserve my own opinion." Ye Liu suppressed the fluctuations in his heart and showed a calm expression on his face.

"GOOD, Ye, you are good." Seeing the scene now, Leo and others had been holding back for a long enough time.

Three black lines almost appeared on Lei Hao's face. How could he not know that a newcomer like Ye Liu deserves to be promoted to his current position? The veteran wants to see the newcomer's ability, and the newcomer is full of confidence. Ready to show off, the equity investment department that had just been integrated with M\u0026G Investment became the area of ​​focus.

Ye Liu represents Chenguang Investment. In Thunder, a group accustomed to investing in high-risk, high-yield projects, he really has too many opportunities to jump out and make a splash.

However...even Ye Liu is not as calm as he appears in his heart.

Objectively speaking, Ye Liu's winning rate is not small, but Lei Hao's record is also very unobjective. He has a lot of confidence.

But everyone knows very well that judging from the results, Ye Liu will definitely "lose", and Li Moutang's project will be piled up with funds by Lei Ting. The only difference is whether the loss will be too severe.

According to the profit prospects of PNH treatment drugs, if Lei Lei invests 200 million yuan in it, it will eventually get good results. In total, it will be a small loss. Taking into account the charity nature, it will be a great success.

Regardless of whether others believe it or not, Ye Liu doesn't believe it, and the Thunder newcomers from the Morning Light series definitely don't believe it, so while other projects are still in contact with each other for the time being, they chose this charity project as their target.

In fact, let alone Ye Liu, Li Gaotang himself didn't believe it, how expensive is it to do drug research? The answer is extremely expensive.

First of all, the equipment and many experimental materials are imported, and they cost US dollars. 200 million yuan is equivalent to 30 million US dollars. The professor spent 5 million in the blink of an eye. What about the remaining 25 million? I'm still staying at the Thunder Charity Foundation and haven't been approved yet.

But it doesn't matter. Li Yutang doesn't really believe that he can use the money to achieve perfect results, but as long as the equipment is gradually in place and the personnel are gradually sufficient, he is confident in raising funds.

As long as there is progress in the experiment, even if the Thunder's money is spent and no more money is given, in Li Miaotang's view, it is an act of benevolence. When he produces results in the future, the military medal will definitely be a share of the Thunder Charity Fund, but he can use it Basically go to other places to raise funds.

The country, other institutions, and other charitable funds. Anyway, once a charity is "shameless" and has the hardware foundation to see the light of day, the energy is huge.

But the professor first had to deceive the 200 million quota given by Lei Hao. Yes, he felt that the word "fool" was used appropriately, and he also knew that Lei Hao knew that he was deceiving, so his little tricks were very frequent, and Very blatant.

"Mr. Lei, this multiple sets of experiments have accumulated a wealth of experience for us and verified many of our arguments. I believe that the final compounds absolutely meet the standards. As long as they pass animal testing, it is very reliable for these active compounds to meet clinical trial standards." Possible things.”

"However, the more active compounds, the better. One more active compound means one more possibility..."

That afternoon, as expected, Lei Hao met Li Gaotang, who had come to "fool" him. What the latter said made Ye Liu, who had been responsible for the operation of the charity fund recently, almost flip the table.

Scientific research is all about burning money. Spending tens or even millions of dollars on an experiment is just like playing. However, Li Gaotang has lost all his moral integrity by talking about an experiment that has made no progress in such a glamorous way.

That was not what Lei Hao was concerned about. What he was dissatisfied with was that Li Gaotang only brought two new experimental plans in addition to the plan he rejected last time.

Fortunately, one of the two plans actually came up with a suitable compound. Although future information shows that this compound will ultimately fail to pass animal testing, it is still a suitable opportunity.

"Except for this plan, I don't approve any other plan." Lei Hao said simply: "Based on the opinions of Thunder Group's expert library, we chose to invest in this plan."

"Which expert rejected other plans?" Scholar Li Miaotang's arrogance was immediately revealed: "I want to have academic exchanges with him."

"Professor Chen of Peking University." Lei Hao said the name, but he saw the disdainful look on Li Miaotang's face, and the other party's "arrogant" words also echoed in the office: "He is indeed good in biology, but In the field of drug research in PNH, I am the authority in China."

"In the field of investment, I am the world's authority. Professor, I now believe in the other party's analysis. What you have to do is... make the denominator bigger for me, make it as big as possible, and Lei Lei will be responsible for choosing the numerator." Lei Hao said unreasonably.

Li Moutang suddenly withered. The world is huge and the capital is the largest. Whoever Lei Hao wants to believe is his freedom. Although academics are very concerned about authority, you can't control which authority the capital is willing to believe.

The most important thing is that Li Miaotang's project requires a lot of research anyway, and he really doesn't lack plans. Anyway, Thunder's funds have completed part of the experimental plans, and others can take over the rest, so... …

"Mr. Lei is right." Li Gaotang once again lost his moral integrity and showed a happy expression on his face. He asked cautiously: "Can I understand that as long as I submit more plans, Mr. Lei, you will be among them? Pick a few to invest in.”

"Yes." Lei Hao nodded.

"That's easy to handle." Li Gaotang said that he realized that he had plenty of brain cells. If he exchanged brain cells for funds, this deal would definitely be a good deal.

Lei Hao also nodded helplessly. He wanted to see if the professor would be so calm when the success rate of his investment plan far exceeded the industry average.

With the same probability, as the denominator becomes larger, the numerator becomes larger accordingly, and the base number can be filtered through future information. As long as Lei Hao guides Li Gaotang to the appropriate track, the research on PNH will definitely progress rapidly. Wait until several kinds of Pharmaceutical companies will naturally take over active compounds that can be used in clinical research.

After all, no matter what, this is a new drug.